Vivo Opportunity Fund Holdings, L.P.
CIK 0001930214 Name as filed on the most recent filing
Filed as Vivo Opportunity Fund Holdings, L.P. (13)
65 transaction lines · from 13 filings · filed 2022-08-16 to 2026-07-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER InMed Pharmaceuticals Inc. 3 filings
- ISSUER Soleno Therapeutics Inc 3 filings
- ISSUER Terns Pharmaceuticals, Inc. 4 filings
- ISSUER Bolt Biotherapeutics, Inc. 2 filings
- ISSUER IO Biotech, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 19 acquired | 1.55 | 29.45 | Form 4, filing 0001213900-26-078891 | |
| 2026-07-16 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 2 acquired | 1.55 | 3.10 | Form 4, filing 0001213900-26-078891 | |
| 2026-07-15 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 13,761 acquired | 1.55 | 21,329.55 | Form 4, filing 0001213900-26-078891 | |
| 2026-07-15 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 1,389 acquired | 1.55 | 2,152.95 | Form 4, filing 0001213900-26-078891 | |
| 2026-07-14 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 4,882 acquired | 1.55 | 7,567.10 | Form 4, filing 0001213900-26-078891 | |
| 2026-07-14 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 493 acquired | 1.55 | 764.15 | Form 4, filing 0001213900-26-078891 | |
| 2026-07-02 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 1,460 acquired | 1.55 | 2,263.00 | Form 4, filing 0001213900-26-075144 | |
| 2026-07-02 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 147 acquired | 1.55 | 227.85 | Form 4, filing 0001213900-26-075144 | |
| 2026-07-01 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 3,946 acquired | 1.55 | 6,116.30 | Form 4, filing 0001213900-26-075144 | |
| 2026-07-01 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 398 acquired | 1.55 | 616.90 | Form 4, filing 0001213900-26-075144 | |
| 2026-06-30 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 545 acquired | 1.54 | 839.30 | Form 4, filing 0001213900-26-075144 | |
| 2026-06-30 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 55 acquired | 1.54 | 84.70 | Form 4, filing 0001213900-26-075144 | |
| 2026-06-08 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 29,518 acquired | 1.52 | 44,867.36 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-08 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 2,982 acquired | 1.52 | 4,532.64 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-05 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 49,966 acquired | 1.57 | 78,446.62 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-05 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 5,045 acquired | 1.57 | 7,920.65 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-04 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 6,125 acquired | 1.57 | 9,616.25 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-04 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 618 acquired | 1.57 | 970.26 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-03 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 7,069 acquired | 1.55 | 10,956.95 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-03 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 714 acquired | 1.55 | 1,106.70 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-02 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 20,753 acquired | 1.52 | 31,544.56 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-02 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 2,095 acquired | 1.52 | 3,184.40 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-01 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 14,838 acquired | 1.55 | 22,998.90 | Form 4, filing 0001213900-26-067505 | |
| 2026-06-01 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 1,498 acquired | 1.55 | 2,321.90 | Form 4, filing 0001213900-26-067505 | |
| 2026-05-29 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 16,164 acquired | 1.57 | 25,377.48 | Form 4, filing 0001213900-26-067505 | |
| 2026-05-29 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 1,632 acquired | 1.57 | 2,562.24 | Form 4, filing 0001213900-26-067505 | |
| 2026-05-21 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 30,882 acquired | 1.69 | 52,190.58 | Form 4, filing 0001213900-26-067505 | |
| 2026-05-21 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 3,118 acquired | 1.69 | 5,269.42 | Form 4, filing 0001213900-26-067505 | |
| 2026-05-20 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 51,056 acquired | 1.56 | 79,647.36 | Form 4, filing 0001213900-26-067505 | |
| 2026-05-20 |
InMed Pharmaceuticals Inc. INM |
P, Open-market purchase | 5,154 acquired | 1.56 | 8,040.24 | Form 4, filing 0001213900-26-067505 | |
| 2025-03-28 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 333,557 disposed | 70.60 | 23,549,124.20 | Form 4, filing 0001013762-25-004322 | |
| 2025-03-27 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 1,100,000 disposed | 67.80 | 74,580,000.00 | Form 4, filing 0001013762-25-004322 | |
| 2025-03-26 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 400,000 disposed | 65.80 | 26,320,000.00 | Form 4, filing 0001013762-25-004322 | |
| 2024-08-29 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 100,000 disposed | 47.22 | 4,722,000.00 | Form 4, filing 0001213900-24-074051 | |
| 2024-08-28 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 425,000 disposed | 47.35 | 20,123,750.00 | Form 4, filing 0001213900-24-074051 | |
| 2024-08-27 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 500,000 disposed | 48.73 | 24,365,000.00 | Form 4, filing 0001213900-24-074051 | |
| 2024-04-30 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 351,242 disposed | 45.13 | 15,851,551.46 | Form 4, filing 0001213900-24-038343 | |
| 2024-04-29 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 750,000 disposed | 47.80 | 35,850,000.00 | Form 4, filing 0001213900-24-038343 | |
| 2024-04-03 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 103,870 disposed | 6.20 | 643,994.00 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-03 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 30,047 disposed | 6.20 | 186,291.40 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-03 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 4,149 disposed | 6.20 | 25,723.80 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-02 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 76,346 disposed | 6.65 | 507,700.90 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-02 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 22,084 disposed | 6.65 | 146,858.60 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-02 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 3,050 disposed | 6.65 | 20,282.50 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-01 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 136,255 disposed | 6.99 | 952,422.45 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-01 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 39,411 disposed | 6.99 | 275,482.89 | Form 4, filing 0001213900-24-030020 | |
| 2024-04-01 |
Terns Pharmaceuticals, Inc. TERN |
S, Open-market sale | 5,451 disposed | 6.99 | 38,102.49 | Form 4, filing 0001213900-24-030020 | |
| 2023-11-21 |
Bolt Biotherapeutics, Inc. BOLT |
S, Open-market sale | 1,707 disposed | 0.90 | 1,536.30 | Form 4, filing 0001213900-23-089692 | |
| 2023-11-21 |
Bolt Biotherapeutics, Inc. BOLT |
S, Open-market sale | 1,457 disposed | 0.90 | 1,311.30 | Form 4, filing 0001213900-23-089692 | |
| 2023-11-21 |
Bolt Biotherapeutics, Inc. BOLT |
S, Open-market sale | 236 disposed | 0.90 | 212.40 | Form 4, filing 0001213900-23-089692 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Vivo Opportunity Fund Holdings, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001930214
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6